Your session is about to expire
← Back to Search
Study Summary
This trial will assess the safety and effectiveness of cedirogant compared to placebo in adults with moderate to severe plaque psoriasis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Cedirogant been given the stamp of approval by the FDA?
"Cedirogant's safety is rated as a 2, given that only preliminary data exists in regards to its efficacy and there are some findings which support it being safe."
Are there any vacancies available for those wishing to participate in this clinical trial?
"As confirmed by clinicaltrials.gov, the recruitment phase of this specific medical trial has now concluded; it was originally posted on November 16th 2021 and last updated on November 11th 2022. However, there are still 167 other trials that remain open to enrollment at present."
What are the criteria for enrollment in this clinical trial?
"This trial is looking for 200 individuals aged between 18 and 65 who have been living with psoriasis for a minimum of 6 months. To qualify, applicants must meet the following prerequisites: - Patients diagnosed with moderate-to-severe plaque psoriasis that requires systemic or phototherapy treatment."
How many medical facilities have been enlisted to conduct this experiment?
"Currently, this medical trial is enrolling patients from thirteen distinct sites. These are scattered across the US and Canada, including Atlanta, Calgary and Spokane amongst other locales. It's important to choose a nearby clinic for convenience should you join the study."
Is this experiment available to elderly individuals?
"The eligibility requirements stipulate that the minimum age of enrolment must be 18 and no more than 65 years old."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger